Global Clot Busting Drugs Market Continues Upward Trajectory, Projected to Reach US$ 58.4 Billion by 2032 with a 7.3% CAGR

The global clot-busting drugs market is poised for substantial growth, with an estimated market value of around US$ 28.8 billion in 2022. Projections indicate a robust Compound Annual Growth Rate (CAGR) of 7.3%, driving the market to soar to a valuation of US$ 58.4 billion by the end of 2032. Among other thrombotic diseases, thrombolytics—a term …

Global Clot-Busting Drugs Market For Remarkable Growth, Expected to Reach US$ 58.4 Billion by 2032, at a 7.3% CAGR

The global clot-busting drugs market is anticipated to grow at a compound annual growth rate (CAGR) of 7.3%, reaching US$ 58.4 billion by the end of 2032, up from an estimated US$ 28.8 billion in 2022. The injectable mode of administration currently leads the global market for clot-busting medications as of 2021. Clot-busting drugs, also …